Integrated Research Limited

IRI Details

AGM Update: Integrated Research Limited (ASX: IRI) offers performance monitoring and management software solutions for unified communications, payment networks, and business computing environments.

Reduction in Total Expenses; (Analysis by Kalkine Group)
Key Risks: The company faces the risk of higher development costs and technology obsoletion. Regulatory changes and expansion to new markets also pose a challenge to business growth.
Outlook:
Valuation Methodology: P/E Multiple Based Relative Valuation (Illustrative)

Source: Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation: The stock of IRI gave a negative return of ~31.68% in the past three months and a negative return of ~40.35% in the past six months. The stock is currently trading lower than the 52-weeks’ average price level band of $1.135 - $3.100. The stock has been valued using the P/E multiple-based illustrative relative valuation method and arrived at a target price of low double-digit upside (in % terms). The company might trade at a slight discount than its peers’ average P/E multiple, considering the uncertainty of time in the recognition of revenue from SaaS contracts, changing client needs, and structural changes in the industry, etc. For this purpose of valuation, a few peers like Infomedia Limited (ASX: IFM), Iress Limited (ASX: IRE), Nuix Limited (ASX: NXL) have been considered. Considering the current trading levels, customer growth and retention, diversification towards a new revenue model, the launch of new products, plans for continued investment in products and platform, valuation, and associated key business risks, we give a ‘Speculative Buy’ rating on the stock at the closing market price of $1.175, down by ~1.261% as of 22 December 2021.


IRI Daily Technical Chart, Data Source: REFINITIV
Tesserent Limited

TNT Details

Partnership with Vocus: Tesserent Limited (ASX: TNT) provides networking and cyber security solutions to mid-market, corporate, critical infrastructure, and government clients. It operates Pure Security Group, North, and IT Security Managed Services as its core segments. On 21 December 2021, TNT declared entering a partnership with Vocus. As per a newly signed master reseller agreement, TNT will provide its Cyber 360 solutions to Vocus’ 5,000 plus- government and enterprise clients. The management believes this alliance will improve TNT’s profitable organic growth and access to new clients.
Conversion of Options: On 10 December 2021, Director, Gregory David Baxter disposed of ~1.5 million options and acquired ~1.5 million ordinary shares in the company. He held ~5.40 million ordinary shares and 3.00 million unlisted options in TNT.
Financial & Market Update:

The trend of Earnings from FY15-FY21; (Analysis by Kalkine Group)
Key Risks: The company faces cyber security threats, technological changes, regulatory hurdles, and the risk of synergies from multiple recent acquisitions.
Outlook:
Valuation Methodology: EV/Sales Multiple Based Relative Valuation (Illustrative)

Source: Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation: The stock of TNT gave a negative return of ~30.43% in the past three months and a negative return of ~38.46% in the past six months. The stock is currently trading lower than the 52-weeks’ average price level band of $0.150 - $0.440. The stock has been valued using the Enterprise Value to Sales based illustrative relative valuation method and arrived at a target price of low double-digit upside (in % terms). The company might trade at some discount than its peers’ median EV/Sales multiple, considering the continuing trend of negative margin, negative ROE, risk of acquisition synergies, and forex rate fluctuations. For this purpose of valuation, few peers like Integrated Research Limited (ASX: IRI), Adacel Technologies Limited (ASX: ADA), Reckon Limited (ASX: RKN), and others have been considered. Considering the current trading levels, expanded client base with recent partnership and acquisitions, growth in ARR and turnover, indicative upside in the valuation, and associated key business risks, we give a ‘Speculative Buy’ rating on the stock at the closing market price of $0.160, down by ~3.031% as of 22 December 2021.


TNT Daily Technical Chart, Data Source: REFINITIV
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decision should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the Valuation has been achieved and subject to the factors discussed above.
Technical Indicators Defined: -
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Past performance is not a reliable indicator of future performance.